Navigating the Trough: Investment Strategy for the CRO & Biotech R&D Sector Turnaround

I. Executive Summary: The Great R&D Reset The Contract Research Organization (CRO) industry is in the late stages of a cyclical downturn, precipitated by a severe contraction in biotech funding that began in 2022 and persisted through the first half of 2025. This “biotech winter” was a direct consequence of a fundamental shift in the […]